Yamamoto K, Kohda Y, Sawada Y, Iga T
Department of Pharmacy, University of Tokyo Hospital, Faculty of Medicine, University of Tokyo, Japan.
Biopharm Drug Dispos. 1991 Nov;12(8):613-25. doi: 10.1002/bdd.2510120807.
The pharmacokinetics of ambenonium, a reversible cholinesterase inhibitor, in rats was investigated following intravenous administration of the drug. Mean residence time and steady state volume of distribution were 23-36 min and 0.20-0.311 kg-1, respectively, and were dose independent at the dose of 0.3-3 mumole kg-1. Total body clearance of 8.2 ml min-1 kg-1 over 0.3 mumole kg-1 was slightly increased to 11.3 ml min-1 kg-1 at 3 mumole kg-1. Renal clearance was also increased with the increase of the dose, while hepatobiliary clearance was substantially constant. Ambenonium was highly concentrated in the liver, kidney, spleen, and lung. About 30 per cent of the dose is concentrically stored in the liver at 6 h after administration, and had not disappeared after 24 h.
在大鼠静脉注射可逆性胆碱酯酶抑制剂氨苯铵后,对其药代动力学进行了研究。平均驻留时间和稳态分布容积分别为23 - 36分钟和0.20 - 0.311 kg⁻¹,在0.3 - 3微摩尔/千克的剂量下与剂量无关。在0.3微摩尔/千克时,总体清除率为8.2毫升/分钟/千克,在3微摩尔/千克时略有增加至11.3毫升/分钟/千克。肾清除率也随剂量增加而增加,而肝胆清除率基本恒定。氨苯铵在肝脏、肾脏、脾脏和肺中高度浓缩。给药后6小时,约30%的剂量集中储存在肝脏中,24小时后仍未消失。